UNH vs CVS: which stock is the better buy?
UnitedHealth Group Incorporated and CVS Health Corp., graded by the same fixed-weight model from live fundamentals — composite score, 12-month forecast, valuation, growth and margins, side by side. As of July 6, 2026.
On today’s numbers, UnitedHealth Group Incorporated grades higher — 58/100 vs 57/100. Tap either card for the full factor breakdown.
Metric by metric
| Metric | UNH | CVS |
|---|---|---|
| TradersQuant Score | 58/100 ✓ | 57/100 |
| Price | $425.36 | $104.72 |
| 12-mo base forecast | $491.88 | $120.00 |
| Implied upside | +15.6% ✓ | +14.6% |
| Bull / bear range | $556.01 / $455.71 | $134.44 / $111.76 |
| P/E | 32.1 ✓ | 45.5 |
| Forward P/E | — | — |
| Revenue growth (YoY) | +11.8% ✓ | +7.8% |
| Gross margin | 18.8% ✓ | 13.9% |
| Market cap | $386.3B | $133.6B |
| Sector | Healthcare | Healthcare |
✓ marks the stronger reading per metric (lower is better for P/E). Figures refresh continuously; research, not financial advice.
Want the full verdict on UNH and CVS?
The AI bull/base/bear thesis, smart-money positioning, options signals and insider activity on both — every systematic call graded in public against the S&P 500.
$0 today · cancel before day 7 and you won’t be charged
UNH vs CVS — FAQ (2026)
Is UNH or CVS the better buy right now?
On the live TradersQuant composite score, UnitedHealth Group Incorporated (UNH) currently grades higher at 58/100 versus 57/100 for CVS. The score weighs valuation, growth, earnings quality, momentum, the macro regime, sentiment and balance-sheet risk — open each stock's page for the full breakdown. Research, not financial advice.
Which has more 12-month upside, UNH or CVS?
TradersQuant's 12-month base-case forecast currently implies +15.6% for UNH and +14.6% for CVS. Both forecasts are three-scenario models (bull/base/bear) refreshed continuously and graded on our public track record.
How is this UNH vs CVS comparison calculated?
Both stocks are scored by the same fixed-weight model — 20% valuation, 20% growth, 15% earnings quality, 15% momentum, 10% macro regime fit, 10% analyst sentiment, 10% balance-sheet risk — from live fundamentals and prices. No hand-picking: the same arithmetic runs on every stock we cover, and our systematic calls are graded in public against the S&P 500.